You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

ISOVUE-128 Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Isovue-128 patents expire, and what generic alternatives are available?

Isovue-128 is a drug marketed by Bracco and is included in one NDA.

The generic ingredient in ISOVUE-128 is iopamidol. There are eleven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the iopamidol profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Isovue-128

A generic version of ISOVUE-128 was approved as iopamidol by HAINAN POLY on February 27th, 2023.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ISOVUE-128?
  • What are the global sales for ISOVUE-128?
  • What is Average Wholesale Price for ISOVUE-128?
Drug patent expirations by year for ISOVUE-128
Recent Clinical Trials for ISOVUE-128

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
NYU Langone HealthN/A
M.D. Anderson Cancer CenterN/A
National Cancer Institute (NCI)N/A

See all ISOVUE-128 clinical trials

Pharmacology for ISOVUE-128

US Patents and Regulatory Information for ISOVUE-128

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco ISOVUE-128 iopamidol INJECTABLE;INJECTION 018735-005 Oct 21, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.